Cargando…
Assessment of serum symmetric dimethylarginine and creatinine concentrations in hyperthyroid cats before and after a fixed dose of orally administered radioiodine
BACKGROUND: Serum symmetric dimethylarginine (SDMA) is a sensitive renal biomarker for detecting early chronic kidney disease (CKD) in nonhyperthyroid cats, but knowledge regarding its performance in hyperthyroid cats remains limited. OBJECTIVES: To determine the relationship between serum SDMA, cre...
Autores principales: | Yu, Lucia, Lacorcia, Lauren, Finch, Sue, Johnstone, Thurid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379014/ https://www.ncbi.nlm.nih.gov/pubmed/32506701 http://dx.doi.org/10.1111/jvim.15831 |
Ejemplares similares
-
Assessment of symmetric dimethylarginine as a biomarker of renal function in hyperthyroid cats treated with radioiodine
por: Buresova, Eva, et al.
Publicado: (2019) -
Hyperthyroid cats and their kidneys: a literature review
por: Yu, L, et al.
Publicado: (2022) -
Evaluation of Renal Perfusion in Hyperthyroid Cats before and after Radioiodine Treatment
por: Stock, E., et al.
Publicado: (2017) -
Evaluation of Serum Symmetric Dimethylarginine Concentration as a Marker for Masked Chronic Kidney Disease in Cats With Hyperthyroidism
por: Peterson, M.E., et al.
Publicado: (2018) -
Plasma symmetric dimethylarginine and creatinine concentrations and glomerular filtration rate in cats with normal and decreased renal function
por: Brans, Marleen, et al.
Publicado: (2020)